IL108155A - Pharmaceutical preparations containing 71 alpha-dihydroquilinene or its aster or salt - Google Patents

Pharmaceutical preparations containing 71 alpha-dihydroquilinene or its aster or salt

Info

Publication number
IL108155A
IL108155A IL10815593A IL10815593A IL108155A IL 108155 A IL108155 A IL 108155A IL 10815593 A IL10815593 A IL 10815593A IL 10815593 A IL10815593 A IL 10815593A IL 108155 A IL108155 A IL 108155A
Authority
IL
Israel
Prior art keywords
salt
pharmaceutically acceptable
pharmaceutical composition
alpha
dihydroequilin
Prior art date
Application number
IL10815593A
Other languages
English (en)
Hebrew (he)
Other versions
IL108155A0 (en
Original Assignee
American Home Prod
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US08/157,661 external-priority patent/US5482935A/en
Application filed by American Home Prod filed Critical American Home Prod
Publication of IL108155A0 publication Critical patent/IL108155A0/xx
Publication of IL108155A publication Critical patent/IL108155A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
IL10815593A 1993-01-05 1993-12-23 Pharmaceutical preparations containing 71 alpha-dihydroquilinene or its aster or salt IL108155A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US77793A 1993-01-05 1993-01-05
US08/157,661 US5482935A (en) 1993-01-05 1993-12-01 Anti-atherosclerotic use of 17 alpha-dihydroequilin

Publications (2)

Publication Number Publication Date
IL108155A0 IL108155A0 (en) 1994-04-12
IL108155A true IL108155A (en) 1999-08-17

Family

ID=26668138

Family Applications (1)

Application Number Title Priority Date Filing Date
IL10815593A IL108155A (en) 1993-01-05 1993-12-23 Pharmaceutical preparations containing 71 alpha-dihydroquilinene or its aster or salt

Country Status (17)

Country Link
EP (1) EP0678027B1 (es)
JP (1) JP3344585B2 (es)
CN (1) CN1071573C (es)
AT (1) ATE209495T1 (es)
AU (1) AU6015794A (es)
CA (1) CA2152187A1 (es)
CY (1) CY2361B1 (es)
DE (1) DE69331237T2 (es)
DK (1) DK0678027T3 (es)
ES (1) ES2165382T3 (es)
HK (1) HK1011282A1 (es)
IL (1) IL108155A (es)
MX (1) MX9400254A (es)
PH (1) PH30474A (es)
PT (1) PT678027E (es)
SG (1) SG52359A1 (es)
WO (1) WO1994015612A1 (es)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6855703B1 (en) * 2000-03-10 2005-02-15 Endeavor Pharmaceuticals Pharmaceutical compositions of conjugated estrogens and methods of analyzing mixtures containing estrogenic compounds

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3507889A (en) * 1968-06-11 1970-04-21 American Home Prod Process for the preparation of 17alpha-dihydroequilenin and related compounds
US3608075A (en) * 1969-07-28 1971-09-21 American Home Prod Compositions and methods of treating the menopausal syndrome
US4154820A (en) * 1976-02-23 1979-05-15 Akzona Incorporated Compositions containing alkali metal sulfate salts of conjugated estrogens and antioxidants as stabilizers
US4379780A (en) * 1980-09-29 1983-04-12 American Home Products Corporation 17 α-Dihydroequilin hapten and assay method

Also Published As

Publication number Publication date
DE69331237D1 (de) 2002-01-10
HK1011282A1 (en) 1999-07-09
MX9400254A (es) 1994-08-31
ES2165382T3 (es) 2002-03-16
CY2361B1 (en) 2004-06-04
EP0678027B1 (en) 2001-11-28
EP0678027A1 (en) 1995-10-25
ATE209495T1 (de) 2001-12-15
PH30474A (en) 1997-05-28
DK0678027T3 (da) 2002-03-18
CN1071573C (zh) 2001-09-26
WO1994015612A1 (en) 1994-07-21
AU6015794A (en) 1994-08-15
SG52359A1 (en) 1998-09-28
JP3344585B2 (ja) 2002-11-11
IL108155A0 (en) 1994-04-12
CN1096443A (zh) 1994-12-21
DE69331237T2 (de) 2002-06-13
PT678027E (pt) 2002-04-29
CA2152187A1 (en) 1994-07-21
JPH08505392A (ja) 1996-06-11

Similar Documents

Publication Publication Date Title
US5482935A (en) Anti-atherosclerotic use of 17 alpha-dihydroequilin
JP2003527416A (ja) 結合型エストロゲンと酢酸メドロキシプロゲステロンとの組合せを用いたホルモン補充療法
AU2001250034A1 (en) Hormone replacement therapy using a combination of conjugated estrogens and medroxyprogesterone acetate
JPH01500431A (ja) 閉経前の女性に対するホルモン置換治療および避妊保護のための医薬組成物
AU2002336245A1 (en) Hormone replacement therapy
WO2002074292A2 (en) Hormone replacement therapy
EP0666747B1 (en) Use of 17alpha-dihydroequilenin for lowering cholesterol
Cohen et al. Aspirin does not inhibit cholesterol cholelithiasis in two established animal models
EP0678027B1 (en) Anti-atherosclerotic agents
JP2005530791A (ja) 結合型エストロゲンとトリメゲストンの組み合わせを用いたホルモン補充療法
JPH03294230A (ja) 子宮内膜症治療剤
JP2005530790A (ja) 閉経後の障害を治療するためのトリメゲストンおよびエストロゲン
CA2100086C (en) Compositions and methods for alleviating menopausal symptoms
JP2005527574A (ja) ホルモン補充療法におけるトリメゲストンと組み合わせた結合型エストロゲンの使用
JP2005527577A (ja) ホルモン補充療法
JP2002534469A (ja) エストロゲン及びデルタ−ゴナジエン−２１−オール−３，２０−ジオンの使用
von Eickstedt et al. Sex hormones and related compounds including hormonal contraceptives
CA2483846A1 (en) Use of conjugated estrogens in combination with trimegestone in hormone replacement therapy
Bell STUDIES ON THE MECHANISM OF CHOLESTEROL LOWERING BY SULFONATE ESTERS AND THE INFLUENCE OF DIET ON THE HYPOCHOLESTEREMIC RESPONSE IN THE RAT.
JPH10101567A (ja) プロラクチンレベルに対して中立効果を有するエストロゲンの医薬組成物
IL96926A (en) Pharmaceutical compositions for alleviating post-menopausal symptoms comprising melatonin and a least one estrogen and/ or androgen
EP1857110A2 (en) Hormone replacement therapy

Legal Events

Date Code Title Description
FF Patent granted
KB Patent renewed
HCA Change of name of proprietor(s) after amalgamation
KB Patent renewed
MM9K Patent not in force due to non-payment of renewal fees